38 results on '"Thamarai, T."'
Search Results
2. Solar power embedded based SVPWM generator for three phase inverter
- Author
-
Thamarai, T., primary and Kashwan, K. R., additional
- Published
- 2015
- Full Text
- View/download PDF
3. Validation methods implemented to ascertain the positional data uncertainty of an indigenously developed drifter buoy-Pradyu
- Author
-
Srinivasan, R., primary, Zacharia, Shijo, additional, Thamarai, T., additional, and Sudhakar, Tata, additional
- Published
- 2013
- Full Text
- View/download PDF
4. Design and performance of a low power moored data buoy system
- Author
-
Srinivasan, R., primary, Zacharia, Shijo, additional, Thamarai, T., additional, Sudhakar, Tata, additional, and Atmanand, M. A., additional
- Published
- 2011
- Full Text
- View/download PDF
5. Design of an advanced Acoustic Tide Gauge for Tsunami monitoring
- Author
-
Zacharia, Shijo, primary, Srinivasan, R., additional, Thamarai, T., additional, Ramadass, G. A., additional, and Atmanand, M. A., additional
- Published
- 2011
- Full Text
- View/download PDF
6. Transposon mutagenesis screen in Klebsiella pneumoniae identifies genetic determinants required for growth in human urine and serum.
- Author
-
Gray J, Torres VVL, Goodall E, McKeand SA, Scales D, Collins C, Wetherall L, Lian ZJ, Bryant JA, Milner MT, Dunne KA, Icke C, Rooke JL, Schneiders T, Lund PA, Cunningham AF, Cole JA, and Henderson IR
- Subjects
- Humans, Klebsiella Infections microbiology, Klebsiella Infections urine, Mutagenesis, Insertional, Serum microbiology, Mutagenesis, Klebsiella pneumoniae genetics, Klebsiella pneumoniae growth & development, DNA Transposable Elements genetics, Urine microbiology
- Abstract
Klebsiella pneumoniae is a global public health concern due to the rising myriad of hypervirulent and multidrug-resistant clones both alarmingly associated with high mortality. The molecular mechanisms underpinning these recalcitrant K. pneumoniae infection, and how virulence is coupled with the emergence of lineages resistant to nearly all present-day clinically important antimicrobials, are unclear. In this study, we performed a genome-wide screen in K. pneumoniae ECL8, a member of the endemic K2-ST375 pathotype most often reported in Asia, to define genes essential for growth in a nutrient-rich laboratory medium (Luria-Bertani [LB] medium), human urine, and serum. Through transposon directed insertion-site sequencing (TraDIS), a total of 427 genes were identified as essential for growth on LB agar, whereas transposon insertions in 11 and 144 genes decreased fitness for growth in either urine or serum, respectively. These studies not only provide further knowledge on the genetics of this pathogen but also provide a strong impetus for discovering new antimicrobial targets to improve current therapeutic options for K. pneumoniae infections., Competing Interests: JG, VT, EG, SM, DS, CC, LW, ZL, JB, MM, KD, CI, JR, TS, PL, AC, JC, IH No competing interests declared, (© 2023, Gray, Torres et al.)
- Published
- 2024
- Full Text
- View/download PDF
7. Noteworthy synthesis strategies and applications of metal-organic frameworks for the removal of emerging water pollutants from aqueous environment.
- Author
-
Sundararaman S, Adhilimam, Chacko J, D P, M K, Kumar JA, A S, P T, M R, and Bokov DO
- Subjects
- Adsorption, Sustainable Development, Metal-Organic Frameworks chemistry, Water Purification methods, Water Pollutants, Chemical chemistry, Water Pollutants, Chemical analysis
- Abstract
17 global Sustainable Development Goals (SDGs) were established through the adoption of the 2030 Agenda for Sustainable Development by all United Nations members. Clean water and sanitation (SDG 6) and industry, innovation, and infrastructure (SDG 9) are the SDGs focus of this work. Of late, various new companies delivering metal-organic frameworks (MOFs) have blossomed and moved the field of adsorption utilizing MOFs to another stage. Inside this unique circumstance, this article aims to catch recent advancements in the field of MOFs and the utilizations of MOFs relate to the expulsion of arising contaminations that present huge difficulties to water quality because of their steadiness and possible damage to environments and human wellbeing. Customary water treatment techniques regularly neglect to eliminate these poisons, requiring the advancement of novel methodologies. This study overviews engineering techniques for controlling MOF characteristics for better flexibility, stability, and surface area. A current report on MOFs gathered new perspectives that are amicably discussed in emergent technologies and extreme applications towards environmental sectors. Various applications in many fields that exploit MOFs are being fostered, including gas storage, fluid separation, adsorbents, catalysis, medication delivery, and sensor utilizations. The surface area of a wide range of MOFs ranges from 10
3 to 104 m2 /g, which exceeds the standard permeability of several material designs. MOFs with extremely durable porosity are more significant in their assortment and variety than other classes of porous materials. The work outlines the difficulties encountered in the synthesis steps and suggests ways to make use of MOFs' value in a variety of contexts. This caters to creating multivariate systems enclosed with numerous functionalities, leading to the synthesis of MOFs that offer a synergistic blend of in-built properties and exclusive applications. Additionally, the MOF-related future development opportunities and challenges are discussed., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
8. Rapid evolution of colistin resistance in a bioreactor model of infection of Klebsiella pneumoniae.
- Author
-
Jiménez-Castellanos JC, Waclaw B, Meynert A, McAteer SP, and Schneiders T
- Subjects
- Klebsiella Infections microbiology, Klebsiella Infections drug therapy, Microbial Sensitivity Tests, Humans, Klebsiella pneumoniae genetics, Klebsiella pneumoniae drug effects, Colistin pharmacology, Anti-Bacterial Agents pharmacology, Bioreactors microbiology, Drug Resistance, Bacterial genetics
- Abstract
Colistin remains an important antibiotic for the therapeutic management of drug-resistant Klebsiella pneumoniae. Despite the numerous reports of colistin resistance in clinical strains, it remains unclear exactly when and how different mutational events arise resulting in reduced colistin susceptibility. Using a bioreactor model of infection, we modelled the emergence of colistin resistance in a susceptible isolate of K. pneumoniae. Genotypic, phenotypic and mathematical analyses of the antibiotic-challenged and un-challenged population indicates that after an initial decline, the population recovers within 24 h due to a small number of "founder cells" which have single point mutations mainly in the regulatory genes encoding crrB and pmrB that when mutated results in up to 100-fold reduction in colistin susceptibility. Our work underlines the rapid development of colistin resistance during treatment or exposure of susceptible K. pneumoniae infections having implications for the use of cationic antimicrobial peptides as a monotherapy., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
9. Editorial: Molecular mechanisms of resistance to "last resort" antimicrobials in Enterobacterales.
- Author
-
Osei Sekyere J, Schneiders T, and Majewski P
- Subjects
- Humans, Drug Resistance, Bacterial genetics, Enterobacteriaceae Infections microbiology, Enterobacteriaceae Infections drug therapy, Drug Resistance, Multiple, Bacterial genetics, Anti-Bacterial Agents pharmacology, Enterobacteriaceae drug effects, Enterobacteriaceae genetics
- Abstract
Competing Interests: Author JO was employed by the company Genesis Biotechnology Group. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
10. End-to-end computational approach to the design of RNA biosensors for detecting miRNA biomarkers of cervical cancer.
- Author
-
Baabu PRS, Srinivasan S, Nagarajan S, Muthamilselvan S, Selvi T, Suresh RR, and Palaniappan A
- Abstract
Cervical cancer is a global public health subject as it affects women in the reproductive ages, and accounts for the second largest burden among cancer patients worldwide with an unforgiving 50% mortality rate. Relatively scant awareness and limited access to effective diagnosis have led to this enormous disease burden, calling for point-of-care, minimally invasive diagnosis methods. Here, an end-to-end quantitative unified pipeline for diagnosis has been developed, beginning with identification of optimal biomarkers, concurrent design of toehold switch sensors, and finally simulation of the designed diagnostic circuits to assess performance. Using miRNA expression data in the public domain, we identified miR-21-5p and miR-20a-5p as blood-based miRNA biomarkers specific to early-stage cervical cancer employing a multi-tier algorithmic screening. Synthetic riboregulators called toehold switches specific to the biomarker panel were then designed. To predict the dynamic range of toehold switches for use in genetic circuits as biosensors, we used a generic grammar of these switches, and built a neural network model of dynamic range using thermodynamic features derived from mRNA secondary structure and interaction. Second-generation toehold switches were used to overcome the design challenges associated with miRNA biomarkers. The resultant model yielded an adj. R
2 ∼0.71, outperforming earlier models of toehold-switch dynamic range. Reaction kinetics modelling was performed to predict the sensitivity of the second-generation toehold switches to the miRNA biomarkers. Simulations showed a linear response between 10 nM and 100 nM before saturation. Our study demonstrates an end-to-end computational workflow for the efficient design of genetic circuits geared towards the effective detection of unique genomic/nucleic-acid signatures. The approach has the potential to replace iterative experimental trial and error, and focus time, money, and efforts. All software including the toehold grammar parser, neural network model and reaction kinetics simulation are available as open-source software (https://github.com/SASTRA-iGEM2019) under GNU GPLv3 licence., Competing Interests: The authors declare no competing interests, financial or otherwise., (© 2022 The Authors.)- Published
- 2022
- Full Text
- View/download PDF
11. Corrigendum to: Antibiotic Treatment Regimes as a Driver of the Global Population Dynamics of a Major Gonorrhea Lineage.
- Author
-
Osnes MN, van Dorp L, Brynildsrud OB, Alfsnes K, Schneiders T, Templeton KE, Yahara K, Balloux F, Caugant DA, and Eldholm V
- Published
- 2022
- Full Text
- View/download PDF
12. Antibiotic Treatment Regimes as a Driver of the Global Population Dynamics of a Major Gonorrhea Lineage.
- Author
-
Osnes MN, Dorp LV, Brynildsrud OB, Alfsnes K, Schneiders T, Templeton KE, Yahara K, Balloux F, Caugant DA, and Eldholm V
- Subjects
- Anti-Bacterial Agents pharmacology, Ceftriaxone pharmacology, Gonorrhea drug therapy, Humans, Neisseria gonorrhoeae drug effects, Phylogeography, Anti-Bacterial Agents therapeutic use, Ceftriaxone therapeutic use, Drug Resistance, Bacterial genetics, Gonorrhea microbiology, Neisseria gonorrhoeae genetics
- Abstract
The Neisseria gonorrhoeae multilocus sequence type (ST) 1901 is among the lineages most commonly associated with treatment failure. Here, we analyze a global collection of ST-1901 genomes to shed light on the emergence and spread of alleles associated with reduced susceptibility to extended-spectrum cephalosporins (ESCs). The genetic diversity of ST-1901 falls into a minor and a major clade, both of which were inferred to have originated in East Asia. The dispersal of the major clade from Asia happened in two separate waves expanding from ∼1987 and 1996, respectively. Both waves first reached North America, and from there spread to Europe and Oceania, with multiple secondary reintroductions to Asia. The ancestor of the second wave acquired the penA 34.001 allele, which significantly reduces susceptibility to ESCs. Our results suggest that the acquisition of this allele granted the second wave a fitness advantage at a time when ESCs became the key drug class used to treat gonorrhea. Following its establishment globally, the lineage has served as a reservoir for the repeated emergence of clones fully resistant to the ESC ceftriaxone, an essential drug for effective treatment of gonorrhea. We infer that the effective population sizes of both clades went into decline as treatment schemes shifted from fluoroquinolones via ESC monotherapy to dual therapy with ceftriaxone and azithromycin in Europe and the United States. Despite the inferred recent population size decline, the short evolutionary path from the penA 34.001 allele to alleles providing full ceftriaxone resistance is a cause of concern., (© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.)
- Published
- 2021
- Full Text
- View/download PDF
13. Expression of AraC/XylS stress response regulators in two distinct carbapenem-resistant Enterobacter cloacae ST89 biotypes.
- Author
-
Majewski P, Gutowska A, Sacha P, Schneiders T, Talalaj M, Majewska P, Zebrowska A, Ojdana D, Wieczorek P, Hauschild T, Kowalczuk O, Niklinski J, Radziwon P, and Tryniszewska E
- Subjects
- Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, Carbapenems pharmacology, Humans, Microbial Sensitivity Tests, beta-Lactamases genetics, Cytarabine, Enterobacter cloacae genetics
- Abstract
Background: The growing incidence of MDR Gram-negative bacteria is a rapidly emerging challenge in modern medicine., Objectives: We sought to establish the role of intrinsic drug-resistance regulators in combination with specific genetic mutations in 11 Enterobacter cloacae isolates obtained from a single patient within a 7 week period., Methods: The molecular characterization of eight carbapenem-resistant and three carbapenem-susceptible E. cloacae ST89 isolates included expression-level analysis and WGS. Quantitative PCR included: (i) chromosomal cephalosporinase gene (ampC); (ii) membrane permeability factor genes, e.g. ompF, ompC, acrA, acrB and tolC; and (iii) intrinsic regulatory genes, e.g. ramA, ampR, rob, marA and soxS, which confer reductions in antibiotic susceptibility., Results: In this study we describe the influence of the alterations in membrane permeability (ompF and ompC levels), intrinsic regulatory genes (ramA, marA, soxS) and intrinsic chromosomal cephalosporinase AmpC on reductions in carbapenem susceptibility of E. cloacae clinical isolates. Interestingly, only the first isolate possessed the acquired VIM-4 carbapenemase, which has been lost in subsequent isolates. The remaining XDR E. cloacae ST89 isolates presented complex carbapenem-resistance pathways, which included perturbations in permeability of bacterial membranes mediated by overexpression of ramA, encoding an AraC/XylS global regulator. Moreover, susceptible isolates differed significantly from other isolates in terms of marA down-regulation and soxS up-regulation., Conclusions: Molecular mechanisms of resistance among carbapenem-resistant E. cloacae included production of acquired VIM-4 carbapenemase, significant alterations in membrane permeability due to increased expression of ramA, encoding an AraC/XylS global regulator, and the overproduction of chromosomal AmpC cephalosporinase., (© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
14. New Texture Descriptor Based on Modified Fractional Entropy for Digital Image Splicing Forgery Detection.
- Author
-
Jalab HA, Subramaniam T, Ibrahim RW, Kahtan H, and Noor NFM
- Abstract
Forgery in digital images is immensely affected by the improvement of image manipulation tools. Image forgery can be classified as image splicing or copy-move on the basis of the image manipulation type. Image splicing involves creating a new tampered image by merging the components of one or more images. Moreover, image splicing disrupts the content and causes abnormality in the features of a tampered image. Most of the proposed algorithms are incapable of accurately classifying high-dimension feature vectors. Thus, the current study focuses on improving the accuracy of image splicing detection with low-dimension feature vectors. This study also proposes an approximated Machado fractional entropy (AMFE) of the discrete wavelet transform (DWT) to effectively capture splicing artifacts inside an image. AMFE is used as a new fractional texture descriptor, while DWT is applied to decompose the input image into a number of sub-images with different frequency bands. The standard image dataset CASIA v2 was used to evaluate the proposed approach. Superior detection accuracy and positive and false positive rates were achieved compared with other state-of-the-art approaches with a low-dimension of feature vectors., Competing Interests: The authors declare no conflict of interest.
- Published
- 2019
- Full Text
- View/download PDF
15. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.
- Author
-
Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Stuart Elborn J, and Tunney MM
- Published
- 2018
- Full Text
- View/download PDF
16. The global distribution and spread of the mobilized colistin resistance gene mcr-1.
- Author
-
Wang R, van Dorp L, Shaw LP, Bradley P, Wang Q, Wang X, Jin L, Zhang Q, Liu Y, Rieux A, Dorai-Schneiders T, Weinert LA, Iqbal Z, Didelot X, Wang H, and Balloux F
- Subjects
- Americas epidemiology, Anti-Bacterial Agents pharmacology, Asia epidemiology, Carbapenems pharmacology, Enterobacteriaceae classification, Enterobacteriaceae drug effects, Enterobacteriaceae isolation & purification, Enterobacteriaceae Infections microbiology, Enterobacteriaceae Infections transmission, Escherichia coli Proteins metabolism, Europe epidemiology, Evolution, Molecular, Gene Expression, Gene Transfer, Horizontal, Humans, Plasmids chemistry, Plasmids metabolism, Population Dynamics, Colistin pharmacology, DNA Transposable Elements, Drug Resistance, Multiple, Bacterial genetics, Enterobacteriaceae genetics, Enterobacteriaceae Infections epidemiology, Escherichia coli Proteins genetics, Genome, Bacterial
- Abstract
Colistin represents one of the few available drugs for treating infections caused by carbapenem-resistant Enterobacteriaceae. As such, the recent plasmid-mediated spread of the colistin resistance gene mcr-1 poses a significant public health threat, requiring global monitoring and surveillance. Here, we characterize the global distribution of mcr-1 using a data set of 457 mcr-1-positive sequenced isolates. We find mcr-1 in various plasmid types but identify an immediate background common to all mcr-1 sequences. Our analyses establish that all mcr-1 elements in circulation descend from the same initial mobilization of mcr-1 by an ISApl1 transposon in the mid 2000s (2002-2008; 95% highest posterior density), followed by a marked demographic expansion, which led to its current global distribution. Our results provide the first systematic phylogenetic analysis of the origin and spread of mcr-1, and emphasize the importance of understanding the movement of antibiotic resistance genes across multiple levels of genomic organization.
- Published
- 2018
- Full Text
- View/download PDF
17. Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired β-lactam resistance.
- Author
-
Jiménez-Castellanos JC, Wan Nur Ismah WAK, Takebayashi Y, Findlay J, Schneiders T, Heesom KJ, and Avison MB
- Subjects
- Drug Resistance, Multiple, Bacterial physiology, Humans, Klebsiella pneumoniae genetics, beta-Lactamases genetics, Bacterial Proteins biosynthesis, Cell Membrane Permeability physiology, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae metabolism, Porins biosynthesis, beta-Lactam Resistance physiology
- Abstract
Objectives: In Klebsiella pneumoniae, overproduction of RamA results in reduced envelope permeability and reduced antimicrobial susceptibility but clinically relevant resistance is rarely observed. Here we have tested whether RamA overproduction can enhance acquired β-lactam resistance mechanisms in K. pneumoniae and have defined the envelope protein abundance changes upon RamA overproduction during growth in low and high osmolarity media., Methods: Envelope permeability was estimated using a fluorescent dye accumulation assay. β-Lactam susceptibility was measured using disc testing. Total envelope protein production was quantified using LC-MS/MS proteomics and transcript levels were quantified using real-time RT-PCR., Results: RamA overproduction enhanced β-lactamase-mediated β-lactam resistance, in some cases dramatically, without altering β-lactamase production. It increased production of efflux pumps and decreased OmpK35 porin production, though micF overexpression showed that OmpK35 reduction has little impact on envelope permeability. A survey of K. pneumoniae bloodstream isolates revealed ramA hyperexpression in 3 of 4 carbapenemase producers, 1 of 21 CTX-M producers and 2 of 19 strains not carrying CTX-M or carbapenemases., Conclusions: Whilst RamA is not a key mediator of antibiotic resistance in K. pneumoniae on its own, it is potentially important for enhancing the spectrum of acquired β-lactamase-mediated β-lactam resistance. LC-MS/MS proteomics analysis has revealed that this enhancement is achieved predominantly through activation of efflux pump production., (© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2018
- Full Text
- View/download PDF
18. Comparative effects of overproducing the AraC-type transcriptional regulators MarA, SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella pneumoniae.
- Author
-
Jiménez-Castellanos JC, Wan Ahmad Kamil WN, Cheung CH, Tobin MS, Brown J, Isaac SG, Heesom KJ, Schneiders T, and Avison MB
- Subjects
- Biological Transport, Active, Cell Membrane physiology, Gene Expression Profiling, Microbial Sensitivity Tests, Permeability, Porins metabolism, Proteome analysis, Proteomics, Real-Time Polymerase Chain Reaction, Anti-Bacterial Agents pharmacology, Bacterial Proteins biosynthesis, Drug Resistance, Bacterial, Gene Expression, Genes, Regulator, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae genetics
- Abstract
Objectives: In Klebsiella pneumoniae, overproduction of RamA and RarA leads to increased MICs of various antibiotics; MarA and SoxS are predicted to perform a similar function. We have compared the relative effects of overproducing these four AraC-type regulators on envelope permeability (a combination of outer membrane permeability and efflux), efflux pump and porin production, and antibiotic susceptibility in K. pneumoniae., Methods: Regulators were overproduced using a pBAD expression vector. Antibiotic susceptibility was measured using disc testing. Envelope permeability was estimated using a fluorescent dye accumulation assay. Porin and efflux pump production was quantified using proteomics and validated using real-time quantitative RT-PCR., Results: Envelope permeability and antibiotic disc inhibition zone diameters both reduced during overproduction of RamA and to a lesser extent RarA or SoxS, but did not change following overproduction of MarA. These effects were associated with overproduction of the efflux pumps AcrAB (for RamA and SoxS) and OqxAB (for RamA and RarA) and the outer membrane protein TolC (for all regulators). Effects on porin production were strain specific., Conclusions: RamA is the most potent regulator of antibiotic permeability in K. pneumoniae, followed by RarA then SoxS, with MarA having very little effect. This observed relative potency correlates well with the frequency at which these regulators are reportedly overproduced in clinical isolates., (© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
19. Correction: Elucidation of the RamA Regulon in Klebsiella pneumoniae Reveals a Role in LPS Regulation.
- Author
-
De Majumdar S, Yu J, Fookes M, McAteer SP, Llobet E, Spence SF, Monaghan A, Kissenpfennig A, Ingram RJ, Bengoechea J, Gally DL, Fanning S, Elborn JS, and Schneiders T
- Abstract
[This corrects the article DOI: 10.1371/journal.ppat.1004627.].
- Published
- 2016
- Full Text
- View/download PDF
20. The Asp20-to-Asn Substitution in the Response Regulator AdeR Leads to Enhanced Efflux Activity of AdeB in Acinetobacter baumannii.
- Author
-
Nowak J, Schneiders T, Seifert H, and Higgins PG
- Subjects
- Acinetobacter baumannii genetics, Acinetobacter baumannii metabolism, Amino Acid Substitution, Anti-Bacterial Agents pharmacology, Bacterial Proteins metabolism, DNA-Binding Proteins metabolism, Drug Resistance, Multiple, Bacterial, Ethidium pharmacokinetics, Gene Expression Regulation, Bacterial, Membrane Transport Proteins genetics, Microbial Sensitivity Tests, Acinetobacter baumannii drug effects, Bacterial Proteins genetics, DNA-Binding Proteins genetics, Membrane Transport Proteins metabolism
- Abstract
Overexpression of the resistance-nodulation-cell division-type efflux pump AdeABC is often associated with multidrug resistance in Acinetobacter baumannii and has been linked to mutations in the genes encoding the AdeRS two-component system. In a previous study, we reported that the Asp20→Asn amino acid substitution in the response regulator AdeR is associated with adeB overexpression and reduced susceptibility to the antimicrobials levofloxacin, tigecycline, and trimethoprim-sulfamethoxazole. To further characterize the effect of the Asp20→Asn substitution on antimicrobial susceptibility, the expression of the efflux genes adeB, adeJ, and adeG, and substrate accumulation, four plasmid constructs [containing adeR(Asp20)S, adeR(Asn20)S, adeR(Asp20)SABC, and adeR(Asn20)SABC] were introduced into the adeRSABC-deficient A. baumannii isolate NIPH 60. Neither adeRS construct induced changes in antimicrobial susceptibility or substrate accumulation from that for the vector-only control. The adeR(Asp20)SABC transformant showed reduced susceptibility to 6 antimicrobials and accumulated 12% less ethidium than the control, whereas the Asn20 variant showed reduced susceptibility to 6 of 8 antimicrobial classes tested, and its ethidium accumulation was only 72% of that observed for the vector-only construct. adeB expression was 7-fold higher in the adeR(Asn20)SABC transformant than in its Asp20 variant. No changes in adeG or adeJ expression or in acriflavine or rhodamine 6G accumulation were detected. The antimicrobial susceptibility data suggest that AdeRS does not regulate any resistance determinants other than AdeABC. Furthermore, the characterization of the Asp20→Asn20 substitution proves that the reduced antimicrobial susceptibility previously associated with this substitution was indeed caused by enhanced efflux activity of AdeB., (Copyright © 2016, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
21. Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulation.
- Author
-
De Majumdar S, Yu J, Fookes M, McAteer SP, Llobet E, Finn S, Spence S, Monahan A, Monaghan A, Kissenpfennig A, Ingram RJ, Bengoechea J, Gally DL, Fanning S, Elborn JS, and Schneiders T
- Subjects
- Animals, Anti-Bacterial Agents pharmacology, Antimicrobial Cationic Peptides pharmacology, Base Sequence, Cells, Cultured, Gene Expression Regulation, Bacterial, Genes, Bacterial, Klebsiella Infections genetics, Membrane Transport Proteins genetics, Membrane Transport Proteins metabolism, Mice, Mice, Inbred C57BL, Molecular Sequence Data, Polymyxins pharmacology, Regulon, Bacterial Proteins genetics, Drug Resistance, Multiple, Bacterial genetics, Host-Pathogen Interactions genetics, Klebsiella pneumoniae genetics, Lipopolysaccharides metabolism
- Abstract
Klebsiella pneumoniae is a significant human pathogen, in part due to high rates of multidrug resistance. RamA is an intrinsic regulator in K. pneumoniae established to be important for the bacterial response to antimicrobial challenge; however, little is known about its possible wider regulatory role in this organism during infection. In this work, we demonstrate that RamA is a global transcriptional regulator that significantly perturbs the transcriptional landscape of K. pneumoniae, resulting in altered microbe-drug or microbe-host response. This is largely due to the direct regulation of 68 genes associated with a myriad of cellular functions. Importantly, RamA directly binds and activates the lpxC, lpxL-2 and lpxO genes associated with lipid A biosynthesis, thus resulting in modifications within the lipid A moiety of the lipopolysaccharide. RamA-mediated alterations decrease susceptibility to colistin E, polymyxin B and human cationic antimicrobial peptide LL-37. Increased RamA levels reduce K. pneumoniae adhesion and uptake into macrophages, which is supported by in vivo infection studies, that demonstrate increased systemic dissemination of ramA overexpressing K. pneumoniae. These data establish that RamA-mediated regulation directly perturbs microbial surface properties, including lipid A biosynthesis, which facilitate evasion from the innate host response. This highlights RamA as a global regulator that confers pathoadaptive phenotypes with implications for our understanding of the pathogenesis of Enterobacter, Salmonella and Citrobacter spp. that express orthologous RamA proteins.
- Published
- 2015
- Full Text
- View/download PDF
22. Molecular basis of non-mutational derepression of ramA in Klebsiella pneumoniae.
- Author
-
De Majumdar S, Yu J, Spencer J, Tikhonova IG, and Schneiders T
- Subjects
- Anti-Bacterial Agents pharmacology, Bacterial Proteins chemistry, Bacterial Proteins metabolism, Base Sequence, Gene Order, Genetic Loci, Klebsiella Infections microbiology, Ligands, Microbial Sensitivity Tests, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Phenothiazines chemistry, Phenothiazines metabolism, Phenothiazines pharmacology, Promoter Regions, Genetic, Protein Binding, Transcription, Genetic, Bacterial Proteins genetics, Gene Expression Regulation, Bacterial drug effects, Klebsiella pneumoniae genetics
- Abstract
Objectives: The ram locus, consisting of the romA-ramA genes, is repressed by the tetracycline-type regulator RamR, where regulation is abolished due to loss-of-function mutations within the protein or ligand interactions. The aim of this study was to determine whether the phenothiazines (chlorpromazine and thioridazine) directly interact with RamR to derepress ramA expression., Methods: Quantitative real-time PCR analyses were performed to determine expression levels of the romA-ramA genes after exposure to the phenothiazines. Electrophoretic mobility shift assays (EMSAs) and in vitro transcription experiments were performed to show direct binding to and repression by RamR. Direct binding of the RamR protein to the phenothiazines was measured by fluorescence spectroscopy experiments and molecular docking models were generated using the RamR crystal structure., Results: Exposure to either chlorpromazine or thioridazine resulted in the up-regulation of the romA-ramA genes. EMSAs and in vitro transcription experiments demonstrated that both agents reduce/abolish binding and enhance transcription of the target PI promoter upstream of the ramR-romA genes in Klebsiella pneumoniae compared with RamR alone. Fluorescence spectroscopy measurements demonstrated that RamR directly binds both chlorpromazine and thioridazine with micromolar affinity. Molecular docking analyses using the RamR crystal structure demonstrated that the phenothiazines interact with RamR protein through contacts described for other ligands, in addition to forming unique strong polar interactions at positions D152 and K63., Conclusions: These data demonstrate that phenothiazines can modulate loci linked to the microbe-drug response where RamR is an intracellular target for the phenothiazines, thus resulting in a transient non-mutational derepression of ramA concentrations., (© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
23. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.
- Author
-
Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Elborn JS, and Tunney MM
- Subjects
- Amino Acid Substitution, Anti-Bacterial Agents pharmacology, Bacteroidaceae Infections microbiology, Case-Control Studies, Ceftazidime pharmacology, Cephalosporin Resistance genetics, Genes, Bacterial, Humans, Microbial Sensitivity Tests, Mutation, Prevotella isolation & purification, Tetracycline pharmacology, Tetracycline Resistance genetics, United Kingdom, beta-Lactamases genetics, Cystic Fibrosis microbiology, Drug Resistance, Microbial genetics, Genotype, Prevotella drug effects, Prevotella genetics
- Abstract
Objectives: To investigate mechanisms of reduced susceptibility to commonly used antibiotics in Prevotella cultured from patients with cystic fibrosis (CF), patients with invasive infection and healthy control subjects and to determine whether genotype can be used to predict phenotypic resistance., Methods: The susceptibility of 157 Prevotella isolates to seven antibiotics was compared, with detection of resistance genes (cfxA-type gene, ermF and tetQ), mutations within the CfxA-type β-lactamase and expression of efflux pumps., Results: Prevotella isolates positive for a cfxA-type gene had higher MICs of amoxicillin and ceftazidime compared with isolates negative for this gene (P < 0.001). A mutation within the CfxA-type β-lactamase (Y239D) was associated with ceftazidime resistance (P = 0.011). The UK CF isolates were 5.3-fold, 2.7-fold and 5.7-fold more likely to harbour ermF compared with the US CF, UK invasive and UK healthy control isolates, respectively. Higher concentrations of azithromycin (P < 0.001) and clindamycin (P < 0.001) were also required to inhibit the growth of the ermF-positive isolates compared with ermF-negative isolates. Furthermore, tetQ-positive Prevotella isolates had higher MICs of tetracycline (P = 0.001) and doxycycline (P < 0.001) compared with tetQ-negative isolates. Prevotella spp. were also shown, for the first time, to express resistance nodulation division (RND)-type efflux pumps., Conclusions: This study has demonstrated that Prevotella isolated from various sources harbour a common pool of resistance genes and possess RND-type efflux pumps, which may contribute to tetracycline resistance. The findings indicate that antibiotic resistance is common in Prevotella spp., but the genotypic traits investigated do not reflect phenotypic antibiotic resistance in every instance., (© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
24. Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.
- Author
-
McCaughey G, Gilpin DF, Schneiders T, Hoffman LR, McKevitt M, Elborn JS, and Tunney MM
- Subjects
- Anaerobiosis, Bacterial Proteins genetics, Bacterial Proteins metabolism, Cystic Fibrosis complications, Cystic Fibrosis microbiology, Drug Combinations, Gene Expression Regulation, Bacterial drug effects, Humans, Isoenzymes antagonists & inhibitors, Isoenzymes genetics, Isoenzymes metabolism, Lung drug effects, Lung microbiology, Microbial Sensitivity Tests, Nitrate Reductase genetics, Nitrate Reductase metabolism, Nitrates metabolism, Pseudomonas Infections complications, Pseudomonas Infections microbiology, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa enzymology, Pseudomonas aeruginosa genetics, Transcription, Genetic, Anti-Bacterial Agents pharmacology, Bacterial Proteins antagonists & inhibitors, Cystic Fibrosis drug therapy, Fosfomycin pharmacology, Nitrate Reductase antagonists & inhibitors, Pseudomonas Infections drug therapy, Tobramycin pharmacology
- Abstract
The activity of aminoglycosides, which are used to treat Pseudomonas aeruginosa respiratory infection in cystic fibrosis (CF) patients, is reduced under the anaerobic conditions that reflect the CF lung in vivo. In contrast, a 4:1 (wt/wt) combination of fosfomycin and tobramycin (F:T), which is under investigation for use in the treatment of CF lung infection, has increased activity against P. aeruginosa under anaerobic conditions. The aim of this study was to elucidate the mechanisms underlying the increased activity of F:T under anaerobic conditions. Microarray analysis was used to identify the transcriptional basis of increased F:T activity under anaerobic conditions, and key findings were confirmed by microbiological tests, including nitrate utilization assays, growth curves, and susceptibility testing. Notably, growth in subinhibitory concentrations of F:T, but not tobramycin or fosfomycin alone, significantly downregulated (P < 0.05) nitrate reductase genes narG and narH, which are essential for normal anaerobic growth of P. aeruginosa. Under anaerobic conditions, F:T significantly decreased (P < 0.001) nitrate utilization in P. aeruginosa strains PAO1, PA14, and PA14 lasR::Gm, a mutant known to exhibit increased nitrate utilization. A similar effect was observed with two clinical P. aeruginosa isolates. Growth curves indicate that nitrate reductase transposon mutants had reduced growth under anaerobic conditions, with these mutants also having increased susceptibility to F:T compared to the wild type under similar conditions. The results of this study suggest that downregulation of nitrate reductase genes resulting in reduced nitrate utilization is the mechanism underlying the increased activity of F:T under anaerobic conditions.
- Published
- 2013
- Full Text
- View/download PDF
25. Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.
- Author
-
Sherrard LJ, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Muhlebach MS, Wolfgang MC, Gilpin DF, Elborn JS, Schneiders T, and Tunney MM
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Microbial Sensitivity Tests, Middle Aged, Prevotella isolation & purification, United Kingdom, Young Adult, beta-Lactamases metabolism, Anti-Bacterial Agents pharmacology, Bacteroidaceae Infections microbiology, Cystic Fibrosis complications, Drug Resistance, Bacterial, Prevotella drug effects
- Abstract
Objectives: To compare the antimicrobial susceptibility of Prevotella spp. isolated from cystic fibrosis (CF) and non-CF patients and analyse the impact of antibiotic prescribing in the preceding year on resistance amongst CF isolates., Methods: The susceptibility of 80 CF Prevotella isolates to 12 antibiotics was compared with that of 50 Prevotella isolates from invasive infections in people who did not have CF and 27 Prevotella isolates from healthy controls., Results: All isolates were susceptible to chloramphenicol, meropenem and piperacillin/tazobactam, with only four isolates resistant to metronidazole. However, resistance to amoxicillin, ceftazidime and tetracycline was apparent in all groups. Significant differences in clindamycin resistance (UK CF, 56%; UK invasive, 10%) and co-amoxiclav non-susceptibility (UK CF, 32%; UK invasive, 12%) were observed between UK CF and UK invasive isolates. The likelihood of non-susceptibility to clindamycin and co-amoxiclav in UK CF isolates was 5.5-fold and 2.5-fold higher relative to that in UK invasive isolates, respectively. Azithromycin MICs were also significantly higher for CF isolates (P < 0.001), which was associated with current prescription of azithromycin. More than 50% of clinical isolates tested in this study were β-lactamase positive., Conclusions: This study profiles antibiotic susceptibility in Prevotella spp. in CF and demonstrates that meropenem, piperacillin/tazobactam, chloramphenicol and metronidazole are likely to be the most effective antibiotics if treatment is indicated.
- Published
- 2013
- Full Text
- View/download PDF
26. Prevalence of ST131 virulence-associated strains among CTX-M-producing Escherichia coli in the gut of hospitalized neonates in India.
- Author
-
Roy S, Krishnan R, Mukherjee S, Schneiders T, Niyogi SK, and Basu S
- Subjects
- Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, Drug Resistance, Bacterial genetics, Escherichia coli drug effects, Escherichia coli genetics, Escherichia coli Infections epidemiology, Feces microbiology, Humans, India epidemiology, Infant, Newborn, Infant, Newborn, Diseases epidemiology, Logistic Models, Microbial Sensitivity Tests, Prevalence, Prospective Studies, Risk Factors, beta-Lactam Resistance genetics, beta-Lactamases genetics, Escherichia coli enzymology, Escherichia coli pathogenicity, Escherichia coli Infections microbiology, Infant, Newborn, Diseases microbiology
- Published
- 2013
- Full Text
- View/download PDF
27. Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.
- Author
-
Veleba M, De Majumdar S, Hornsey M, Woodford N, and Schneiders T
- Subjects
- Enterobacter aerogenes genetics, Enterobacter aerogenes isolation & purification, Enterobacter cloacae genetics, Enterobacter cloacae isolation & purification, Gene Expression Profiling, Gene Expression Regulation, Bacterial, Genes, Bacterial, Humans, Membrane Transport Proteins biosynthesis, Membrane Transport Proteins genetics, Minocycline pharmacology, Real-Time Polymerase Chain Reaction, Sequence Analysis, DNA, Tigecycline, Transcription Factors genetics, Transcription Factors metabolism, Anti-Bacterial Agents pharmacology, Drug Resistance, Bacterial, Enterobacter aerogenes drug effects, Enterobacter cloacae drug effects, Enterobacteriaceae Infections microbiology, Minocycline analogs & derivatives
- Abstract
Objectives: The intrinsically encoded ramA gene has been linked to tigecycline resistance through the up-regulation of efflux pump AcrAB in Enterobacter cloacae. The molecular basis for increased ramA expression in E. cloacae and Enterobacter aerogenes, as well as the role of AraC regulator rarA, has not yet been shown. To ascertain the intrinsic molecular mechanism(s) involved in tigecycline resistance in Enterobacter spp., we analysed the expression levels of ramA and rarA and corresponding efflux pump genes acrAB and oqxAB in Enterobacter spp. clinical isolates., Methods: The expression levels of ramA, rarA, oqxA and acrA were tested by quantitative real-time RT-PCR. The ramR open reading frames of the ramA-overexpressing strains were sequenced; strains harbouring mutations were transformed with wild-type ramR to study altered ramA expression and tigecycline susceptibility., Results: Tigecycline resistance was mediated primarily by increased ramA expression in E. cloacae and E. aerogenes. Only the ramA-overexpressing E. cloacae isolates showed increased rarA and oqxA expression. Upon complementation with wild-type ramR, all Enterobacter spp. containing ramR mutations exhibited decreased ramA and acrA expression and increased tigecycline susceptibility. Exceptions were one E. cloacae strain and one E. aerogenes strain, where a decrease in ramA levels was not accompanied by lower acrA expression., Conclusions: Increased ramA expression due to ramR deregulation is the primary mediator of tigecycline resistance in clinical isolates of E. cloacae and E. aerogenes. However, some ramA-overexpressing isolates do not show changes in ramR, suggesting alternate pathways of ramA regulation; the rarA regulator and the oqxAB efflux pump may also play a role in tigecycline resistance in E. cloacae.
- Published
- 2013
- Full Text
- View/download PDF
28. Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae.
- Author
-
De Majumdar S, Veleba M, Finn S, Fanning S, and Schneiders T
- Subjects
- Amaryllidaceae Alkaloids pharmacology, Amitriptyline pharmacology, Bacterial Proteins genetics, Fluoroquinolones pharmacology, Klebsiella pneumoniae genetics, Microbial Sensitivity Tests, Nitrofurans pharmacology, Oxazolidinones pharmacology, Polymyxin B pharmacology, Puromycin pharmacology, Regulon physiology, Anti-Bacterial Agents pharmacology, Bacterial Proteins metabolism, Drug Resistance, Multiple, Bacterial genetics, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae metabolism, Regulon genetics
- Abstract
RarA is an AraC-type regulator in Klebsiella pneumoniae, which, when overexpressed, confers a low-level multidrug-resistant (MDR) phenotype linked to the upregulation of both the acrAB and oqxAB efflux genes. Increased rarA expression has also been shown to be integral in the development of tigecycline resistance in the absence of ramA in K. pneumoniae. Given its phenotypic role in MDR, microarray analyses were performed to determine the RarA regulon. Transcriptome analysis was undertaken using strains Ecl8ΔrarA/pACrarA-2 (rarA-expressing construct) and Ecl8ΔrarA/pACYC184 (vector-only control) using bespoke microarray slides consisting of probes derived from the genomic sequences of K. pneumoniae MGH 78578 (NC_009648.1) and Kp342 (NC_011283.1). Our results show that rarA overexpression resulted in the differential expression of 66 genes (42 upregulated and 24 downregulated). Under the COG (clusters of orthologous groups) functional classification, the majority of affected genes belonged to the category of cell envelope biogenesis and posttranslational modification, along with genes encoding the previously uncharacterized transport proteins (e.g., KPN_03141, sdaCB, and leuE) and the porin OmpF. However, genes associated with energy production and conversion and amino acid transport/metabolism (e.g., nuoA, narJ, and proWX) were found to be downregulated. Biolog phenotype analyses demonstrated that rarA overexpression confers enhanced growth of the overexpresser in the presence of several antibiotic classes (i.e., beta-lactams and fluoroquinolones), the antifungal/antiprotozoal compound clioquinol, disinfectants (8-hydroxyquinoline), protein synthesis inhibitors (i.e., minocycline and puromycin), membrane biogenesis agents (polymyxin B and amitriptyline), DNA synthesis (furaltadone), and the cytokinesis inhibitor (sanguinarine). Both our transcriptome and phenotypic microarray data support and extend the role of RarA in the MDR phenotype of K. pneumoniae.
- Published
- 2013
- Full Text
- View/download PDF
29. Genome Sequence of Klebsiella pneumoniae Ecl8, a Reference Strain for Targeted Genetic Manipulation.
- Author
-
Fookes M, Yu J, De Majumdar S, Thomson N, and Schneiders T
- Abstract
We report the genome sequence of Klebsiella pneumoniae subsp. pneumoniae Ecl8, a spontaneous streptomycin-resistant mutant of strain ECL4, derived from NCIB 418. K. pneumoniae Ecl8 has been shown to be genetically tractable for targeted gene deletion strategies and so provides a platform for in-depth analyses of this species.
- Published
- 2013
- Full Text
- View/download PDF
30. Tigecycline challenge triggers sRNA production in Salmonella enterica serovar Typhimurium.
- Author
-
Yu J and Schneiders T
- Subjects
- Gene Expression Profiling, Klebsiella pneumoniae drug effects, Minocycline metabolism, RNA, Bacterial biosynthesis, Tigecycline, Anti-Bacterial Agents metabolism, Gene Expression Regulation, Bacterial drug effects, Minocycline analogs & derivatives, RNA, Small Interfering biosynthesis, Salmonella typhimurium drug effects
- Abstract
Background: Bacteria employ complex transcriptional networks involving multiple genes in response to stress, which is not limited to gene and protein networks but now includes small RNAs (sRNAs). These regulatory RNA molecules are increasingly shown to be able to initiate regulatory cascades and modulate the expression of multiple genes that are involved in or required for survival under environmental challenge. Despite mounting evidence for the importance of sRNAs in stress response, their role upon antibiotic exposure remains unknown. In this study, we sought to determine firstly, whether differential expression of sRNAs occurs upon antibiotic exposure and secondly, whether these sRNAs could be attributed to microbial tolerance to antibiotics., Results: A small scale sRNA cloning strategy of Salmonella enterica serovar Typhimurium SL1344 challenged with half the minimal inhibitory concentration of tigecycline identified four sRNAs (sYJ5, sYJ20, sYJ75 and sYJ118) which were reproducibly upregulated in the presence of either tigecycline or tetracycline. The coding sequences of the four sRNAs were found to be conserved across a number of species. Genome analysis found that sYJ5 and sYJ118 mapped between the 16S and 23S rRNA encoding genes. sYJ20 (also known as SroA) is encoded upstream of the tbpAyabKyabJ operon and is classed as a riboswitch, whilst its role in antibiotic stress-response appears independent of its riboswitch function. sYJ75 is encoded between genes that are involved in enterobactin transport and metabolism. Additionally we find that the genetic deletion of sYJ20 rendered a reduced viability phenotype in the presence of tigecycline, which was recovered when complemented. The upregulation of some of these sRNAs were also observed when S. Typhimurium was challenged by ampicillin (sYJ5, 75 and 118); or when Klebsiella pneumoniae was challenged by tigecycline (sYJ20 and 118)., Conclusions: Small RNAs are overexpressed as a result of antibiotic exposure in S. Typhimurium where the same molecules are upregulated in a related species or after exposure to different antibiotics. sYJ20, a riboswitch, appears to possess a trans-regulatory sRNA role in antibiotic tolerance. These findings imply that the sRNA mediated response is a component of the bacterial response to antibiotic challenge.
- Published
- 2012
- Full Text
- View/download PDF
31. Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae.
- Author
-
Veleba M and Schneiders T
- Subjects
- Drug Resistance, Multiple, Bacterial genetics, Genes, Bacterial, Klebsiella pneumoniae metabolism, Membrane Transport Proteins genetics, Membrane Transport Proteins metabolism, Microbial Sensitivity Tests, Minocycline pharmacology, Tigecycline, Up-Regulation, Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae genetics, Membrane Transport Proteins biosynthesis, Minocycline analogs & derivatives
- Abstract
Tigecycline resistance in Klebsiella pneumoniae results from ramA upregulation that causes the overexpression of the efflux pump, AcrAB-TolC. Tigecycline mutants, derived from Ecl8ΔramA, can exhibit a multidrug resistance phenotype due to increased transcription of the marA, rarA, acrAB, and oqxAB genes. These findings support the idea that tigecycline or multidrug resistance in K. pneumoniae, first, is not solely dependent on the ramA gene, and second, can arise via alternative regulatory pathways in K. pneumoniae.
- Published
- 2012
- Full Text
- View/download PDF
32. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae.
- Author
-
Veleba M, Higgins PG, Gonzalez G, Seifert H, and Schneiders T
- Subjects
- Anti-Bacterial Agents metabolism, Anti-Bacterial Agents pharmacology, Klebsiella pneumoniae enzymology, Membrane Transport Proteins genetics, Membrane Transport Proteins metabolism, Microbial Sensitivity Tests, Sequence Analysis, DNA, AraC Transcription Factor genetics, Bacterial Proteins genetics, Bacterial Proteins metabolism, Drug Resistance, Multiple, Bacterial genetics, Klebsiella pneumoniae genetics, Klebsiella pneumoniae metabolism, Multidrug Resistance-Associated Proteins genetics, Multidrug Resistance-Associated Proteins metabolism
- Abstract
Transcriptional regulators, such as SoxS, RamA, MarA, and Rob, which upregulate the AcrAB efflux pump, have been shown to be associated with multidrug resistance in clinically relevant Gram-negative bacteria. In addition to the multidrug resistance phenotype, these regulators have also been shown to play a role in the cellular metabolism and possibly the virulence potential of microbial cells. As such, the increased expression of these proteins is likely to cause pleiotropic phenotypes. Klebsiella pneumoniae is a major nosocomial pathogen which can express the SoxS, MarA, Rob, and RamA proteins, and the accompanying paper shows that the increased transcription of ramA is associated with tigecycline resistance (M. Veleba and T. Schneiders, Antimicrob. Agents Chemother. 56:4466-4467, 2012). Bioinformatic analyses of the available Klebsiella genome sequences show that an additional AraC-type regulator is encoded chromosomally. In this work, we characterize this novel AraC-type regulator, hereby called RarA (Regulator of antibiotic resistance A), which is encoded in K. pneumoniae, Enterobacter sp. 638, Serratia proteamaculans 568, and Enterobacter cloacae. We show that the overexpression of rarA results in a multidrug resistance phenotype which requires a functional AcrAB efflux pump but is independent of the other AraC regulators. Quantitative real-time PCR experiments show that rarA (MGH 78578 KPN_02968) and its neighboring efflux pump operon oqxAB (KPN_02969_02970) are consistently upregulated in clinical isolates collected from various geographical locations (Chile, Turkey, and Germany). Our results suggest that rarA overexpression upregulates the oqxAB efflux pump. Additionally, it appears that oqxR, encoding a GntR-type regulator adjacent to the oqxAB operon, is able to downregulate the expression of the oqxAB efflux pump, where OqxR complementation resulted in reductions to olaquindox MICs.
- Published
- 2012
- Full Text
- View/download PDF
33. Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion.
- Author
-
Flockhart AF, Tree JJ, Xu X, Karpiyevich M, McAteer SP, Rosenblum R, Shaw DJ, Low CJ, Best A, Gannon V, Laing C, Murphy KC, Leong JM, Schneiders T, La Ragione R, and Gally DL
- Subjects
- Animals, Escherichia coli O157 genetics, Escherichia coli O157 metabolism, Escherichia coli Proteins genetics, Escherichia coli Proteins metabolism, Gene Deletion, Humans, Phosphoproteins genetics, Phosphoproteins metabolism, Prophages physiology, Sheep, Bacterial Secretion Systems, Escherichia coli Infections microbiology, Escherichia coli O157 virology, Gene Expression Regulation, Bacterial, Prophages genetics
- Abstract
This study has identified horizontally acquired genomic regions of enterohaemorrhagic Escherichia coli O157:H7 that regulate expression of the type III secretion (T3S) system encoded by the locus of enterocyte effacement (LEE). Deletion of O-island 51, a 14.93 kb cryptic prophage (CP-933C), resulted in a reduction in LEE expression and T3S. The deletion also had a reduced capacity to attach to epithelial cells and significantly reduced E. coli O157 excretion levels from sheep. Further characterization of O-island 51 identified a novel positive regulator of the LEE, encoded by ecs1581 in the E. coli O157:H7 strain Sakai genome and present but not annotated in the E. coli strain EDL933 sequence. Functionally important residues of ECs1581 were identified based on phenotypic variants present in sequenced E. coli strains and the regulator was termed RgdR based on a motif demonstrated to be important for stimulation of gene expression. While RgdR activated expression from the LEE1 promoter in the presence or absence of the LEE-encoded regulator (Ler), RgdR stimulation of T3S required ler and Ler autoregulation. RgdR also controlled the expression of other phenotypes, including motility, indicating that this new family of regulators may have a more global role in E. coli gene expression., (© 2011 Blackwell Publishing Ltd and Crown Copyright.)
- Published
- 2012
- Full Text
- View/download PDF
34. In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
- Author
-
Higgins PG, Schneiders T, Hamprecht A, and Seifert H
- Subjects
- Acinetobacter baumannii isolation & purification, Carbapenems therapeutic use, Fatal Outcome, Humans, Male, Middle Aged, Molecular Sequence Data, Reverse Transcriptase Polymerase Chain Reaction, Acinetobacter Infections microbiology, Acinetobacter baumannii drug effects, Acinetobacter baumannii genetics, Bacterial Proteins genetics, Carbapenems pharmacology, Drug Resistance, Bacterial genetics, Mutation, Missense genetics
- Abstract
The mechanism of stepwise acquired multidrug resistance in Acinetobacter baumannii isolates from a hospitalized patient was investigated. Thirteen consecutive multidrug-resistant isolates were recovered from the same patient over a 2-month period. The Vitek 2 system identified the isolates as meropenem-sensitive Acinetobacter lwoffii; however, molecular identification showed that the isolates were A. baumannii. Etest revealed that the isolates were meropenem resistant. The presence of oxacillinase (OXA)-type enzymes were investigated by sequencing. The clonal relatedness of isolates was assessed by pulsed-field gel electrophoresis (PFGE). Expression of the genes encoding the efflux pumps AdeB and AdeJ was performed by semiquantitative real-time reverse transcription-PCR (qRT-PCR). The adeRS two-component system was sequenced. All isolates had identical PFGE fingerprints, suggesting clonal identity. The first six isolates were positive for the novel bla(OXA-164) gene. The following seven isolates, recovered after treatment with a combination of meropenem, amikacin, ciprofloxacin, and co-trimoxazole showed an increase of >7-fold in adeB mRNA transcripts and a missense mutation in bla(OXA-164), converting it to bla(OXA-58). Sequencing revealed a novel mutation in adeR. These data illustrate how A. baumannii can adapt during antimicrobial therapy, leading to increased antimicrobial resistance.
- Published
- 2010
- Full Text
- View/download PDF
35. Emergence of CTX-M Group 1-ESBL producing Klebsiella pneumonia from a tertiary care centre in Karachi, Pakistan.
- Author
-
Khan E, Schneiders T, Zafar A, Aziz E, Parekh A, and Hasan R
- Subjects
- Adult, Anti-Bacterial Agents pharmacology, Bacterial Proteins biosynthesis, Bacterial Proteins genetics, Bacterial Typing Techniques, Blood microbiology, Cluster Analysis, DNA Fingerprinting, DNA, Bacterial genetics, Electrophoresis, Gel, Pulsed-Field, Genetic Variation, Genotype, Hospitals, Humans, Infant, Newborn, Klebsiella pneumoniae genetics, Klebsiella pneumoniae isolation & purification, Microbial Sensitivity Tests, Pakistan, Polymerase Chain Reaction methods, Prospective Studies, Trachea microbiology, Urine microbiology, Wounds and Injuries microbiology, beta-Lactamases genetics, Klebsiella Infections microbiology, Klebsiella pneumoniae classification, Klebsiella pneumoniae enzymology, beta-Lactamases biosynthesis
- Abstract
Background: Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae have been reported previously from Pakistan but the genotypic characteristics of these enzymes is not known. Hence the aim of the study was first to characterise the genotypic content of these beta-lactamases and secondly to assess the clonal relationship of these isolates., Methodology: We analysed 65 non-duplicate ESBL positive, K. pneumoniae isolates prospectively collected based on phenotype as detected using the two-disc method. Isolates were collected from different sources: blood cultures (46.15%; n = 30); tracheal aspirates (24.6%; n = 16); urine (10.7%; n = 7); wound swabs, pus and tissue (18.4%; n = 12). ESBL production was confirmed by the ESBL E-test method and the presence of the blaCTX-M encoding genes was confirmed by polymerase chain reaction. The clonal relationship of clinical isolates was studied by Pulsed Field Gel Electrophoresis., Results: The results showed that 93.84% (n = 61) isolates of K. pneumoniae were positive for the blaCTX-M-1 group. One isolate showed PCR signals for blaCTX-M-25 group. None of our isolates were positive for CTX-M groups 2, 8 and 9. The majority of blaCTX-M positive isolates were genetically unrelated and no epidemic clones were identified., Conclusion: This study reports the emergence of CTX-M groups 1 and 25 producing isolates of K. pneumoniae with genetic diversity in Karachi, Pakistan.
- Published
- 2010
- Full Text
- View/download PDF
36. The marC gene of Escherichia coli is not involved in multiple antibiotic resistance.
- Author
-
McDermott PF, McMurry LM, Podglajen I, Dzink-Fox JL, Schneiders T, Draper MP, and Levy SB
- Subjects
- Escherichia coli genetics, Escherichia coli growth & development, Escherichia coli metabolism, Escherichia coli Proteins metabolism, Gene Expression Regulation, Bacterial, Microbial Sensitivity Tests, Operon, Repressor Proteins genetics, Repressor Proteins metabolism, Anti-Bacterial Agents pharmacology, Drug Resistance, Multiple, Bacterial genetics, Escherichia coli drug effects, Escherichia coli Proteins genetics
- Published
- 2008
- Full Text
- View/download PDF
37. MarA-mediated transcriptional repression of the rob promoter.
- Author
-
Schneiders T and Levy SB
- Subjects
- Base Sequence, Binding Sites, Blotting, Northern, DNA metabolism, DNA-Directed RNA Polymerases metabolism, Electrophoresis, Polyacrylamide Gel, Escherichia coli, Genotype, Models, Genetic, Molecular Sequence Data, Phenotype, Plasmids metabolism, Potassium Permanganate pharmacology, Promoter Regions, Genetic, Protein Binding, RNA metabolism, Trans-Activators metabolism, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, DNA-Binding Proteins physiology, Escherichia coli Proteins genetics, Escherichia coli Proteins metabolism, Escherichia coli Proteins physiology, Gene Expression Regulation, Bacterial, Transcription, Genetic
- Abstract
The Escherichia coli transcriptional regulator MarA affects functions that include antibiotic resistance, persistence, and survival. MarA functions as an activator or repressor of transcription utilizing similar degenerate DNA sequences (marboxes) with three different binding site configurations with respect to the RNA polymerase-binding sites. We demonstrate that MarA down-regulates rob transcripts both in vivo and in vitro via a MarA-binding site within the rob promoter that is positioned between the -10 and -35 hexamers. As for the hdeA and purA promoters, which are repressed by MarA, the rob marbox is also in the "backward" orientation. Protein-DNA interactions show that SoxS and Rob, like MarA, bind the same marbox in the rob promoter. Electrophoretic mobility shift analyses with a MarA-specific antibody demonstrate that MarA and RNA polymerase form a ternary complex with the rob promoter DNA. Transcription experiments in vitro and potassium permanganate footprinting analysis show that MarA affects the RNA polymerase-mediated closed to open complex formation at the rob promoter.
- Published
- 2006
- Full Text
- View/download PDF
38. The Escherichia coli transcriptional regulator MarA directly represses transcription of purA and hdeA.
- Author
-
Schneiders T, Barbosa TM, McMurry LM, and Levy SB
- Subjects
- Cyclic AMP Response Element-Binding Protein metabolism, DNA-Binding Proteins metabolism, Escherichia coli metabolism, Escherichia coli Proteins metabolism, Promoter Regions, Genetic, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Cyclic AMP Response Element-Binding Protein genetics, DNA-Binding Proteins genetics, Escherichia coli genetics, Escherichia coli Proteins genetics, Gene Expression Regulation, Bacterial
- Abstract
The Escherichia coli MarA protein mediates a response to multiple environmental stresses through the activation or repression in vivo of a large number of chromosomal genes. Transcriptional activation for a number of these genes has been shown to occur via direct interaction of MarA with a 20-bp degenerate asymmetric "marbox" sequence. It was not known whether repression by MarA was also direct. We found that purified MarA was sufficient in vitro to repress transcription of both purA and hdeA. Transcription and electrophoretic mobility shift experiments in vitro using mutant promoters suggested that the marbox involved in the repression overlapped the -35 promoter motif and was in the "backward" orientation. This organization contrasts with that of the class II promoters activated by MarA, in which the marbox also overlaps the -35 motif but is in the "forward" orientation. We conclude that MarA, a member of the AraC/XylS family, can act directly as a repressor or an activator, depending on the position and orientation of the marbox within a promoter.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.